Loading...

The global impact of Precision Medicine Group.
As it happens.

Impact, observations, and insights on the evolving healthcare landscape.

Conference: Meeting on the Med, 2024

2024-03-28T11:58:17-04:00Cell & Gene Therapy, Events, Thought Leadership|

Precision will be at this year’s Meeting on the Med, April 9-11, 2023, in Rome, Italy. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the clinical development, manufacturing, and commercialization for cell and gene therapies.

Connect with our Advanced Therapy experts

  • Visit us through any of the numerous networking opportunities at Meeting on the Med 24′
  • Be sure to attend the Precision sponsored workshop on April 9, 2024, at 5:15 PM CET |Location: Rome Cavalieri, A Waldorf Astoria Hotel

You can register for Meeting on the Med below:

REGISTER HERE

(more…)

Read More

Conference: Gene Therapy for Rare Disorders (GTRD), 2024

2024-03-13T15:14:52-04:00Cell & Gene Therapy, Events, Thought Leadership|

Precision will be at this year’s Gene Therapy for Rare Disorders on March 26-29, 2024, in Boston, MA. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the clinical development, manufacturing, and commercialization for gene therapies.

Speaking Engagements
Detailed descriptions for each speaking engagement are included below. 

  • Precision will have a plenary speaking position on March 27, 2024, 8:30 – 9:00 am.
  • Precision’s Andy Kinley (VP, Innovation & Clinical Science, Precision for Medicine) will Chair the Clinical track session, “Clinical Endpoints for Rare Disease Studies,” on March 28, 2024, 11:15 am – 12:15 pm.

Connect with our Advanced Therapy experts

  • Schedule in-person or virtual meetings with our team

—

Plenary Speaking Position: What to Look Forward to for Gene Therapy in 2024
Precision | March 27, 2024, 8:30 – 9AM ET 

  • Key Takeaways
    • Market trends and expectations for Gene Therapies & Rare Diseases in 2024 
    • Predictions on Potential Approvals in 2024 
    • Innovative Trends & Technologies 
    • Evolution of CMC and manufacturing 

Speakers:

  • [Moderator] Jake Greenwood, VP, Project Farma  
  • Faraz Ali, CEO, Tenaya Therapeutics  
  • Debs Phippard, CSO, Precision for Medicine  
  • Frank Bugg, Global Head of BaseCamp Operations & Commercial, ElevateBio  

Panel Discussion: Manufacturing Track: Capacity versus Capability – Moving Towards Innovative Manufacturing Processes
Precision | March 28, 2024, 11:15AM – 12:15PM ET

  • Andy Kinley, VP, Innovation & Clinical Science (Precision for Medicine) to Chair
Read More

Article: Scrip Asks…What Does 2024 Hold For Biopharma? Part 3: Manufacturing And Supply

2024-01-30T08:32:06-05:00Cell & Gene Therapy, Thought Leadership|

Precision’s Anshul Mangal weighs in on what to expect in 2024 regarding biopharma manufacturing and supply-related issues in this Scrip Asks Part 3 series.

“Cell and gene therapies will continue to dominate the innovative clinical pipeline with the largest number of treatments in clinical trials (589 gene therapies and 568 cell therapies). The recent historic landmark of the first CRISPR technology gaining regulatory approval signals confidence in this approach. Additionally, as the adoption of radioligand therapy increases, it continues to show profound potential. One of the most promising aspects of radioligand therapy lies in the potential to create unique combinations of radioactive atoms and targeting molecules tailored to specific tumor types.” (subscription required):

(more…)

Read More

Article: Connecting Institutions and Global Sites: Q&A With Sofia Baig, President of Clinical Solutions at Precision for Medicine

2024-01-24T17:53:03-05:00Cell & Gene Therapy, Thought Leadership|

As clinical trial protocols have become more complex in recent years, institutions are facing new challenges in keeping up with the advancements. In this Q&A, Precision’s Sofia Baig, President of Clinical Solutions, discusses the challenges these institutions are facing, how sites can keep pace with new technologies, and improving efficiency in early and later phase research.

(more…)

Read More

Article: AAV-based gene therapies hold promise for treating CNS conditions

2024-01-04T09:01:10-05:00Thought Leadership|

Meaningful progress is being made in the development of gene therapies for rare neurological diseases caused by single gene mutations. AAV-based therapeutics have been the most successful in vivo gene therapies for patients with central nervous system disorders. Precision’s Deb Phippard identifies challenges to their development with assessing, minimizing and mitigating immunogenicity.

(more…)

Read More

Conference: Advanced Therapies Week, 2024

2023-12-18T15:43:36-05:00Cell & Gene Therapy, Events, Thought Leadership|

Precision will be at this year’s Advanced Therapies Week, January 16 – 19, in Miami, FL. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the clinical development, manufacturing, and commercialization for advanced therapies.

Speaking Engagements
Detailed descriptions for each speaking engagement are included below. 

  • Precision will chair the opening plenary session on January 17, 2024, 9:00 – 10:30 am.
  • Precision will chair panel discussion ‘Non-Viral Solutions for Gene Therapy’ on January 19, 2024, 10:00 – 11:00 am.
  • Project Farma will sponsor the ‘Yacht Party – Under The Stars’ on January 17, 2024, 7:30 – 9:00 pm.
  • Precision will host the opening remarks and present the Cell Therapy Biotech Innovation Award at the Advanced Therapies Awards Ceremony on January 18, 2024.

Connect with our Advanced Therapy experts

  • Visit us through any of the numerous networking opportunities at Advanced Therapies Week
  • Be sure to attend the Project Farma sponsored ‘Yacht Party – Under The Stars’ on January 17, 2024, 7:00 – 9:30 pm
  • Join us for the Advanced Therapies Awards Ceremony on January 18, 2024, 7:00 pm – 12:00 am
  • Schedule an in-person or virtual meeting with our team

You can register for Advanced Therapies Week below:

REGISTER HERE

(more…)

Read More

Precision Medicine Group Releases Its Inaugural Environmental, Social and Governance (ESG) Report

2023-12-14T08:40:44-05:00Cell & Gene Therapy, News, Thought Leadership|

Precision is proud to have published our inaugural 2023 Environmental, Social and Governance (ESG) Report, reflecting the company’s ongoing efforts to do better for our people, in our practices, and with the broader community at large. This year’s report shares key achievements, performance metrics, and steps we have taken to enhance sustainability throughout the company, including:

· Engaging internal and external stakeholders in our company’s first ESG materiality assessment to identify and prioritize our material issues

· Defining Precision’s approach to ESG in our company’s ESG Strategy Statement · Creating a three-year strategic ESG Roadmap for advancing our performance across environmental, social, and governance issues · Initiating energy efficiency projects and standards across our facilities

· Implementing implicit bias training for our Executive Leadership Team and Human Resources leaders

· Contributing volunteer hours by over 425 employees and over $250,000 in donations to more than 70 charitable foundations and causes

 

(more…)

Read More
Load More Posts

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

© Precision Medicine Group, LLC.
All Rights Reserved.